These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16267753)

  • 1. Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.
    Garbino J
    Clin Infect Dis; 2005 Dec; 41(11):1690-1. PubMed ID: 16267753
    [No Abstract]   [Full Text] [Related]  

  • 2. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
    Thomas F; Mebtouche B; Clavier H; Kalfon P
    Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadequate proof of adverse outcome due to the use of fluconazole in critically ill patients.
    Blot SI; Hoste EA; Vandewoude KH; Colardyn FA
    Arch Surg; 2000 Sep; 135(9):1114. PubMed ID: 10982521
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifocal Candida species colonization as a trigger for early antifungal therapy in critically ill patients: what about other risk factors for fungal infection?
    Charles PE
    Crit Care Med; 2006 Mar; 34(3):913-4. PubMed ID: 16505683
    [No Abstract]   [Full Text] [Related]  

  • 6. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of critically ill patients with candidemia.
    Mensa J; Pitart C; Marco F
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S93-7. PubMed ID: 19013347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timely selection of adequate antifungal therapy for candidemia in the critically ill: don't let the yeast rise!
    Corona A; Cislaghi F; Singer M
    Crit Care Med; 2008 Nov; 36(11):3097-8. PubMed ID: 18941310
    [No Abstract]   [Full Text] [Related]  

  • 11. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
    Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
    Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH; Guglielmo BJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients.
    Magill SS; Swoboda SM; Johnson EA; Merz WG; Pelz RK; Lipsett PA; Hendrix CW
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):293-301. PubMed ID: 16698215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA; Kim HG; Long L
    J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
    Odds FC
    Clin Infect Dis; 2003 May; 36(10):1229-31. PubMed ID: 12746766
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
    Garey KW; Neuhauser MM; Bearden DT; Cannon JP; Lewis RE; Gentry LO; Kontoyiannis DP
    Mycoses; 2006 May; 49(3):226-31. PubMed ID: 16681815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To treat or not to treat--critically ill patients with candiduria.
    Hollenbach E
    Mycoses; 2008 Sep; 51 Suppl 2():12-24. PubMed ID: 18721329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida famata fungemia in a surgical patient successfully treated with fluconazole.
    Carrega G; Riccio G; Santoriello L; Pasqualini M; Pellicci R
    Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):698-9. PubMed ID: 9352267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.